Glenmark Pharma Announces 48th AGM on Sep 11, 2026

Glenmark Pharmaceuticals Limited has announced its 48th Annual General Meeting (AGM) will be held on Friday, September 11, 2026, at 2:00 p.m. IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM) in compliance with MCA and SEBI regulations. The company has also released its Integrated Annual Report, including BRSR for the Financial Year 2025-26, which is available on the company's website and NSDL's e-voting portal. Key agenda items include the adoption of audited standalone and consolidated financial statements for FY26, declaration of a dividend of INR 2.50 per equity share, re-appointment of Mrs. Blanche Saldanha as a Non-Executive Director, and ratification of the Cost Auditor's remuneration for FY27.